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The Expression,Stability, and Enzymatic Activity 
of Specific Beta-Lactamase Mutants 
ABSTRACT 
Three catalytic site mutants (ser 70 to thr, thr 71 to 
ser, and the double mutant ser 70 to thr-thr 71 to ser) of 
the pBR 322 beta-lactamase were purified to homogeneity. 
These mutant proteins were unstable and could only be 
obtained from E.coli at 30o c, rather than the normal growth 
temperature of 37o. The use of the strong tac promoter 
increased the yield of the thr 71 to ser mutant protein. 
This promoter was coupled with a kanamycin resistance gene 
to create a new vector for the expression of inactive beta-
lactamase mutants. A new purification protocol for the pBR 
322 lactamase was devised. By replacing an early ion-
exchange chromatography column with an ammonium sulfate 
precipitation, it was possible to isolate unstable beta-
lactamases in high yield . 
The ser 70 to thr mutant and the double mutant show no 
catalytic activity and do not form an acyl enzyme 
intermediate. However, they do still retain the ability to 
bind benzylpenicillin. The thr 71 to ser mutant is active. 
The Km values for benzylpenicillin and cephalothin 
hydrolysis are unchanged from the wild-type enzyme, while 
the kcat values are approximately 15 % of the wild-type 
value. This mutant also cleaves the poor substrate 
cefoxitin, again with no significant change in Km, but with 
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kcat reduced to 8 % of the wild-type value. Examination of 
the pre-steady state burst during cefoxitin hydrolysis 
showed that the thr 71 to ser enzyme acylated at the same 
rate and to at least 80 % of the extent of the wild-type 
enzyme. Direct measurement of the deacylation rate 
confirmed that a reduction in the deacylation rate is 
responsible for the lowered reaction rate in this mutant 
protein. Additionally, this protein lost catalytic activity 
at elevated temperature more rapidly than the wild-type 
enzyme. 
The denaturation of the active thr 71 to ser mutant was 
observed in more detail. This enzyme thermally denatures at 
45°, a temperature 10 to 15° lower than that required to 
denature the wild-type enzyme. This mutant is also more 
susceptible to digestion by thermolysin, trypsin, and those 
proteases present in vivo in the periplasmic space of 
E.coli. The enzyme also loses activity at a urea 
concentration of 2 M, whereas the wild-type enzyme is still 
active at urea concentrations greater than 4 M. The 
inactive mutants ser 70 to thr and ser 70 to thr-thr 71 to 
ser are even more susceptible to proteolytic attack by 
E.coli proteases in vivo. 
A mutant pBR 322 beta-lactamase lacking the disulfide 
bond found in the wild-type enzyme was also purified to 
homogeneity. This 
catalytic activity 
protein showed 
relative to the 
no alterations 
wild-type enzyme 
in 
at 
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temperatures below 40°. Above this temperature, this enzyme 
rapidly lost activity. This enzyme was also more 
susceptible to proteolytic attack at elevated temperature. 
However, this enzyme is more resistant to thermal and 
proteolytic denaturation than the thr 71 to ser mutant beta-
lactamase. 
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Nomenclature 
The beta-lactamase amino acid residues are numbered 
according to the consensus sequence (R.P.Ambler, Phil.Trans. 
Roy.Soc.London SerB 289:321-331, 1980) . Mutations in this 
protein are presented in the form S70T, where the first 
letter represents the amino acid in the wild-type protein, 
the number is the position of the amino acid, and the second 
letter represents the amino acid present in the mutant 
enzyme. 
Abbreviations 
Tris-HCl,tris(hydroxymethyl)aminomethane hydrochloride; 
IPTG, isopropylthiogalactoside; SDS-PAGE,sodium dodecylsul-
fate polyacryamide gel electrophoresis; EDTA,ethylenediam-
inetetraacetic acid. 
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CHAPTER I 
INTRODUCTION 
2 
The linear sequence of amino acids in a protein 
uniquely determines its precise three-dimensional structure. 
A major goal of biochemistry is to learn the principles by 
which the primary amino acid sequence of a protein dictates 
this three-dimensional structure and how this structure in 
turn dictates the wide variety of biological functions 
proteins perform. 
The three-dimensional structures of a few of the myriad 
of naturally occurring proteins have been directly determined 
using diffraction techniques. Other physical methods, such 
as ultraviolet,visible, and nuclear magnetic resonance spec-
troscopy, have provided clues to the relationships between 
structure and function in solution for a larger group of 
proteins. However, historically the most widely used tech-
nique for examining structure-function relationships in 
proteins has been to chemically perturb the structure (with 
varying degrees of specificity) and then examine the altered 
protein for resulting changes in function. 
An especially interesting subset of altered proteins are 
those in which a specific amino acid is replaced by one or 
more of the 19 other amino acids naturally occuring in pro-
teins. These changes, along with deletions and insertions, 
are the only possible alterations in protein primary struc-
ture that could be produced by an organism. The production 
of a serine to cysteine "chemical mutation" using the tech-
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niques of organic chemistry has been achieved in subtilisin 
(1,2). Similar mutations have been reported in trypsin (ser 
to cys)(3) and in papain (cys to ser)(4). An "enzymatic 
muta-tion" was described for the soybean trypsin inhibitor, 
in which specific enzymatic digestions were followed by 
resynthesis to produce an arg to lys mutation(5). However, 
these two approaches are far from general. Until recently, 
most amino acid substitutions were provided by non-specific 
mutations. Additionally, homologous proteins from different 
species have been compared, allowing inferences to be made 
about the roles of conserved (and non-conserved) amino acids. 
This comparative approach has provided valuable insights into 
the biochemistry of cytochrome c(6) and serine proteases(7), 
to name two examples. 
Oligonucleotide-directed site specific mutagenesis has 
proven to be a powerful technique for examining the roles 
specific amino acid residues play in a wide variety of pro-
tein functions. This power derives from the ability of this 
technique to uniquely alter specific residues. This tech-
nique has been the subject of several recent reviews (8-10). 
If the protein studied confers a selectable phenotype on the 
host cell, active revertants from an inactive mutant previ-
ously generated using site-specific mutagenesis can be 
isolated(ll). Using this approach, one can couple phenotypic 
information from this classic genetic technique with the 
detailed investigation of the functional properties of a 
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purified mutant protein. This synthesis of molecular gene-
tics with protein biochemistry can reveal alterations in 
protein function due to subtle structural changes whose 
synthesis would not otherwise be attempted. 
In addition to its value in studying the functional 
roles played by amino acids, site-directed mutagenesis has 
also provided information about the role specific amino acids 
play in stabilizing protein molecules against denaturation. 
Attempts have been made to increase the thermal stability of 
proteins by introduction of cysteine residues at positions 
which would allow disulfide bonds to form(l2-14); however, 
this procedure requires accurate structural information on 
the protein in question. Frequently, the additional disul-
fide provides no additional stability to the altered protein. 
One of the first proteins to be extensively examined for 
alterations in catalysis and stability caused by structural 
changes produced using site directed mutagenesis was the 
beta-lactamase encoded by the E.coli plasmid pBR322(11,15). 
The remainder of the introduction will review the properties 
of this protein, and other bacterial proteins that interact 
with penicillin. 
One of the major factors which gives bacteria resistance 
to penicillin and related .B-lactam antibiotics is the pre-
sence of .B-lactamases. Due to this clinical importance, 
.B-lactamases have been the subject of a vast amount of re-
search. Through this research, a significant knowledge 
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about the mechanism of this enzyme has been obtained. 
However, the roles specific amino acid residues, other than 
serine 70, play in the reactions catalyzed by this enzyme are 
not well understood. 
the rational design 
In addition to providing a basis for 
of specific enzyme inhibitors and 
resistant antibiotics, exploring the mechanism of B-lactam-
ases may also contribute to an understanding of the mecha-
nisms used by other hydrolytic enzymes, especially those 
acting on other amides, such as serine proteases. 
B-Lactamases (EC 3. 5. 2. 6) catalyze the hydrolytic clea-
vage of the cyclic amide bond in the four-membered ring of 
penicillins and cephalosporins, as shown in Figure I-1. The 
study of this enzyme dates from 1940, when Abraham and Chain 
discovered that extracts from various bacteria inactivated 
penicillin(16). It soon became apparent that these penicil-
lin-inactivating enzymes varied in physical properties, 
depending on which organism was used as a source. B-Lactam-
ases are found in blue-green algae, virtually all bacteria, 
and most actinomycetes(17). The presence of B-lactamase in 
these diverse organisms, many of which would not be expected 
to encounter B-lactam antibiotics in their normal environ-
ment, suggests that some of these B-lactamases may have 
other, as yet unknown substrates(18). 
Penicillin and related B-lactam antibiotics block bacte-
rial growth by inhibiting the enzymes involved in cell wall 
biosynthesis. Tipper and Strominger proposed that this 
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inhibition is based on the structural resemblance between the 
.B-lactam region of penicillin and the D-ala-D-ala peptide 
bond cleaved in formation of crosslinks in bacterial cell 
wall peptidoglycan(l9). 
If a bacterium is exposed to radioactive penicillin a 
number of proteins, specific for each species, are found 
which covalently bind the antibiotic(Reviewed in 17). These 
penicillin-binding proteins (PBPs) fall into two functional 
classes. The larger proteins (molecular weight 90-100,000) 
are peptidoglycan transpeptidases. These proteins have only 
recently been isolated and their properties are largely 
unknown. The smaller proteins (molecular weight 25-50,000) 
are D-ala-D-ala carboxypeptidases. A number of these pro-
teins have been isolated and extensively characterised. 
Although these functional definitions overlap (for example, 
most carboxypeptidases are capable of transpeptidation under 
certain conditions), the physiological role of each enzyme is 
specific. Though not all PBPs have identifiable functions, 
those known to be required for bacterial growth cannot be 
replaced by other proteins. It is this inhibion of the 
irreplaceable enzymes needed for the synthesis and maintai-
nance of cell walls that allows penicillin to kill bacteria. 
Many different classification schemes for organizing 
the various .B-lactamases have been proposed. Classification 
schemes for .B-lactamase are based on molecular weight, isoe-
lectric point, presence of metal ions, and substrate pro-
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file(20). It should be noted that one species of bacteria 
can produce more than one type of £-lactamase. The scheme I 
will use here splits £-lactamases into three categories, A, 
B, and c, based on size, substrate hydrolysis profile, and 
sequence homology(21,22). However, it is likely that there 
are additional, as yet uncharacterized, classes. 
The type A £-lactamases have an active site serine and a 
molecular weight of about 30,000. These enzymes are found in 
both gram positive and gram negative bacteria. Membrane 
associated forms are also known. These are the best charac-
terized £-lactamases. The pBR322 £-lactamase examined in 
this work is a class A enzyme. 
The type B £-lactamases are metalloproteins with a 
molecular weight of about 22,000 and only two examples are 
known. They show little substrate specificity, cleaving all 
beta-lactams equally well, and are unaffected by the usual 
lactamase inhibitors. These enzymes require zinc (II) or 
cobalt(II) and appear to function as general acid-base 
catalysts with a branched pathway mechanism(23). No evidence 
of an acylenzyme intermediate in this class of £-lactamase 
has been found. 
The type c £-lactamases are similar to the type A en-
zymes in that both types produce an acylenzyme intermediate 
using a serine residue. The type C lactamases differ in that 
their molecular weight is about 39,000 and they are sensitive 
to exogenous nucleophiles. For example, the E.coli chromoso-
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mal lactamase (ampC) can transfer the penicilloyl group of 
its acyl enzyme intermediate to alcohols, resulting in ester 
formation(24). The ampC enzyme can also hydrolyze penicil-
loyl esters. No evidence for these two reactions has been 
found in type A B-lactamases. The rate of cephem cleavage is 
increased for class C lactamases when hydroxylamine is added 
to the solvent, while the class A lactamases show no rate en-
hancement under these conditions. The class c lactamases 
generally hydrolyze cephems rapidly relative to their hydro-
lysis rate for penams; in contrast, the class A lactamases 
hydrolyze penams much more rapidly than they hydrolyze ce-
phems. 
One of the factors contributing to the clinical impor-
tance of B-lactamases is the ability of the genes encoding 
these proteins to migrate from one bacterial species to 
another. Many plasmid encoded B-lactamases are expressed in 
multiple host bacterial species. Changing of the host 
species doesn't affect the specific properties of a plasmid 
encoded B-lactamase, but it can affect the amount of enzyme 
produced(25, 26). In addition, B-lactamases were among the 
first selectable markers found on transposable sequences. 
These TnA transposable sequences can mediate the movement of 
B-lactamase genes between plasmids and bacterial chromo-
somes(27). 
The pBR322 B-lactamase was originally isolated from the 
Tnl (formerly TnA) transposon carried by plasmid Rl drd 19. 
9 
This enzyme and many similar plasmid encoded B-lactamases are 
often referred to as RTEM B-lactamases, named after the type 
strain of E.coli from which the first enzyme of this type was 
isolated ( 28) . These RTEM B-lactamases are similar in size 
(Molecular weight 25-30,000), substrate profile, and isoelec-
tric point(pH 5.4-5.6). These enzymes hydrolyze penicillins 
much faster than they hydrolyze cephalosporins. Isoelectric 
focusing separates these enzymes into two subclasses, the 
first with an isoelectric point of 5.4(RTEM1), the second 
with an isoelectric point of 5.6(RTEM-2). The pBR322 enzyme 
used in this project is the RTEM-1 enzyme. This protein is 
synthesized as a 286 amino acid preprotein containing a 23 
amino acid leader sequence which is removed when the protein 
is exported to the periplasmic space of E.coli(29,30) The 
RTEM proteins are the only lactamases that possess a disul-
fide bond(31,32). 
Five RTEM enzymes have been sequenced and they are 
homologous in primary structure(21). Two of these enzymes-
(the pBR322 enzyme and the RPl lactamase) are almost identi-
cal and differ only at one amino acid residue. At residue 
37, the pBR 322 enzyme possesses a gln, while the RP 1 enzyme 
has a lys at this position. Comparison of these enzymes with 
the other RTEM enzymes (Staphylococcus aureus PCl, Bacillus 
cereus I, and B.licheniformis) yields amino acid sequence 
homologies of 20 to 46 %. 
When the sequences of B-lactamases and pencillin binding 
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proteins are compared, one region of homology, centered on 
the active site serine, is found(33). Covalent labeling with 
presumed active site directed reagents has confirmed the 
identity of this serine as the site of acylenzyrne formation. 
In both types of protein, a conserved lysine residue is found 
at the third position to the carboxyl side of the acylated 
serine residue. B-Lactamases and D-ala carboxypeptidases 
also show a striking resemblance when their secondary struc-
tures are compared(34). 
The class A and C B-lactamases and penicillin binding 
proteins can be viewed as two extremes of a common reaction 
pathway. In both proteins, penicillins form acylenzyrne 
intermediates. In 
rapidly hydrolyze, 
the B-lactamases, these intermediates 
resulting in catalytic hydrolysis of 
penicillins. In the case of the penicillin binding proteins, 
these acylenzyrne intermediates have a long life. Addition of 
a good nucleophile such as hydroxylamine speeds the breakdown 
of this acyl enzyme intermediate. Thus penicillin can be 
viewed as a poor substrate acting as a competitive inhibitor 
of normal cell-wall synthesis reactions . Support for this 
model comes from the observation that penicillin binding 
proteins act as poor B-lactamases, and that B-lactamases can, 
however poorly, hydrolyze depsipeptides that are analogs of 
the substrates cleaved by D-ala-D-ala carboxypeptidases(35). 
This supports the hypothesis that B-lactamases originated as 
a result of mutations to penicillin binding proteins. These 
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mutations have resulted in the increase of the deacylation 
rate of penicillin bound as an acyl enzyme. 
The B-lactamase gene encoded on plasmid pBR322(bla) has 
proven to be a convenient system for the study of many bio-
chemical processes. It possesses an easily transferred 
coding sequence that can be readily expressed in many organ-
isms, both procayotic and eucaryotic. The enzyme confers an 
easily selectable phenotype on the host organism and a number 
of chromogenic substrates are available for accurate deter-
mination of the amount of active enzyme. This gene has been 
used to examine protein 
proteins(37), and as 
secretion(36), expression of fusion 
a marker for experiments examining 
control of gene expression(38). 
12 
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Figure I-1: The inactivation of (a) penicillin and (b) 
cephalosporin by beta-lactamase. In both cases, the beta-
lactam bond is broken by a hydrolytic mechanism. In (a) , 
the product penicilloic acid is relatively stable, while the 
corresponding cephalosporin product in (b) is unstable and 
decomposes spontaneously. R and R represent variable side 
chains. 
A 
B 
Rb~:, 
0 l COOH 
13-lactamase 
Penicillin 
R>1<)-R' 
COOH 
13 -Jactamase 
Cephalosporin 
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Penicilloic acid 
RNH~JR' 
0 OH ~ 
COOH 
Cephalosporoic acid 
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CHAPTER II 
THE EXPRESSION AND PURIFICATION OF 
UNSTABLE BETA-LACTAMASE MUTANTS 
18 
Introduction 
One of the major advantages of using plasmid-encoded 
B-lactamase as a model system for site-directed mutagene-
sis and site saturation is the ability to easily detect 
changes in the phenotype of the host bacterial cell. This 
allows one to rapidly screen for activity in mutant enzymes 
and to search for active revertants of known inactive mu-
tants. However, the use of phenotype alone is inadequate to 
describe the alterations in function of mutant proteins. The 
efficacy of a B-lactam antibiotic depends on its ability to 
pass through the cell wall or outer membrane of bacteria, to 
resist the effect of B-lactamase activity, and to interact 
with the target proteins in the inner membrane. Changes in 
the permeability of the outer cell membrane are particularly 
important as resistance mechanisms in gram negative bacteria 
such as E.coli. Alterations in all of these three processes 
have produced B-lactam resistant phenotypes(Reviewed in 1). 
Altered B-lactamases that lack activity or confer 
reduced resistance to selecting antibiotics may have any of 
several types of defects. The altered protein may be synthe-
sized or secreted at a reduced rate, or the protein may be 
improperly localized. The mutant protein may be catalyti-
cally competent, yet due to reduced ability to withstand 
thermal or proteolytic degradation, confer an antibiotic 
sensitive phenotype on the host cell. Lastly, of course, the 
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mutant protein may be inherently catalytically inactive. 
The active-site mutants of B-lactamase discussed here 
show no alterations in rate of secretion or ability to serve 
as substrate for signal peptidase. Though pulse-chase exper-
iments show that these mutants are synthesized and exported 
normally and are stable for short time periods ( 2) , these 
experiments do not reveal the catalytic competence of these 
mutant enzymes or the ability of these proteins to withstand 
thermal and proteolytic degradation over longer time periods. 
To resolve these ambiguities, it is necessary to produce 
interesting mutant enzymes in sufficient quantity and purify 
them to homogeneity without causing denaturation, if possi-
ble. In this chapter, I will discuss the techniques used to 
produce and purify unstable mutant B-lactamases. In addi-
tion, immunological assays that do not depend on enzyme 
activity were developed. 
Materials and Methods 
Bacterial cell lines. E.coli strain LSl(a derivative of 
HBlOl) (3) was used for all plasmid preparations and as a host 
cell for enzyme production using the intrinsic pBR322 promo-
ters. E.coli strain 01210 was used as a host cell for all 
plasmids containing the tac promoter. Protease deficient 
E.coli strains SG 4121 and SG 3325 were generous gifts from 
J. Rossi. 
Plasmids. All DNA fragments were purified on agarose 
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gels using standard procedures(4). Fragments were isolated 
from the agarose using an electroeluter (International Bio-
technologies, Inc. model UEA). Table II-1 shows the plas-
mids used and their origins. 
Growth media. For all enzyme production fermentations, 
rich media were used. If tetracycline(20 mg/1) was used as 
the selecting antibiotic, FB [ 1 1 of water containing 25 g 
tryptone, 7.5 g yeast extract, 6 g sodium chloride, and 50 ml 
1 M Tris-HCl(ph 7.5)] was used. For selection using 
ampicillin (10-20 mg/1) or kanamycin(30-50 mg/1), XB [1 1 of 
water containing 25 g tryptone, 7.5 g yeast extract, 20 ml 1M 
magnesium sulfate, and 50 ml 1M Tris-HCl(ph 7 . 5)] was used. 
A New Brunswick Magnaferm fermenter(12 1) was used with 
vigorous aeration (10 1/min) and stirring (200 rpm). The use 
of double distilled ultrapure water in the growth media 
increased the yield of beta-lactamase . 
For production of enzyme, frozen starter cultures of 
E. coli containing appropriate plasmid were used. These were 
produced by adding 5 ml MLT [ 10 g tryptone, 5 g yeast 
extract, 5 g sodium chloride, 100 ml 1M Tris-HCl(pH 7.4) per 
liter] to a fresh agar plate and gently suspending the 
cells. One ml of this suspension was added to 0.1 ml sterile 
glycerol and quickly frozen. Fifty ~1 of this suspension was 
added to 10 ml broth to initiate growth. 
Tryptone and yeast extract were from Difco Laboratories, 
and antibiotics were obtained from Sigma . All buffer pH 
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values were measured at 22°C. 
Osmotic shock procedure. E. coli were grown to the 
desired stage and harvested by gentle centrifugation(GSA 
rotor, 5 krpm for 5-10 min or J-6 rotor, 4.2 krpm for 15-20 
min). The collected cells were washed with 50 mM Tris-HCl, 
ph 7. 0 and concentrated by centrifugation as above. The 
collected cells were gently suspended in hyperosmotic su-
crose[450 g sucrose, 0.5 g Na2EDTA, 25 mM Tris-HCl(pH 7.0) 
per 1] and gently stirred at room temperature for 3 0 min-
utes. The cells were gathered by centrifugation(GSA rotor, 
10 krpm, 30 min) and resuspended in ice-cold water. This 
cell slurry was vigorously stirred in the cold room for 30 
minutes. The cells were removed by centrifugation (GSA, 10 
krpm, 15-20 min) and the supernatant used for further purifi-
cation. Sodium azide (0.2 % wjv) was added at this point as 
a preservative. 
Sonication. Cells were gathered by gentle centrifuga-
tion and washed with ice-cold 0.1 M potassium phosphate 
buffer, pH 7.0. After reconcentrating the cells, they were 
resuspended in the same buffer (10 ml per 1 g wet cells). 
Eight ml portions of this suspension were broken using a 
Braunsonic 1510 sonicator set at 100 W for 2 minutes(or until 
the solution was clear). Cooling was maintained using an 
icebath. The cell debris was removed by centrifugation(SS34 
rotor, 5 krpm, 20 min) and the supernatant assayed for pro-
tein and B-lactamase activity. 
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Enzyme assays. Activities were determined by measuring 
the change in absorbance with time at 240 nm of a solution 
containing 1 mM benzylpenicillin and 100 mM sodium phosphate, 
pH 7.0 at 30°C(5). These are the standard assay conditions 
used throughout this work. During purification, the inactive 
mutant B-lactamase was assayed either by direct SDS-PAGE on 
12 % acrylamide gels (6) and comparison with wild-type con-
trols after silver staining (7) or by precipitating with 
rabbit anti-B-lactamase antibodies (see immunoprecipitation 
below). 
Generation of anti-B-lactamase antibody. The initial 
innoculation utilized SDS-PAGE purified wild-type B-lactam-
ase. One mg of protein in an acrylamide gel slice (dialyzed 
to remove free acrylamide and SDS) was lyophilized, mashed in 
a mortar and pestle, and mixed with Freund's complete adju-
vant. This material was injected into the popliteal lymph 
nodes of a rabbit. After 1 month, booster subcutaneous 
innoculations of 100 ~g of purified B-lactamase in incomplete 
Freund's adjuvant were followed by ear-bleeding one week 
later. The blood was allowed to clot for 2-4 hours, then the 
serum was collected by centrifugation. Serum samples were 
screened for presence of anti-B-lactamase antibody by precip-
itin ring test assays. 
Immunoprecipitation. Antigen(ca. 20 ~g) and 15 ~1 
rabbit anti-B-lactamse serum were incubated on ice for 60 min 
in 100 ~1 total volume. Two hundred ~1 of reconstituted goat 
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antirabbit immunoglobin immunobeads(Biorad) was added to each 
sample and incubated on ice for an additional 3 0 min. The 
precipitate was collected (Microfuge, 1 min) and washed by 
resuspension three times in buffer[0.01 M Tris-HCl(pH 7.3), 
0.15 M NaCl, 0.5% Triton-X100]. After removal of the final 
wash, 100 ~1 of elution buffer [0.063 M Tris-HCl(pH 6.8), 2% 
SDS, 2% fresh B-mercaptoethanol] was added and the pellet was 
resuspended by vortexing. The samples were boiled in a water 
bath for 2 min, and the precipitate was removed by centrifu-
gation. After addition of glycerol and pyronin-Y, the super-
natants were analyzed by electrophoresis through 12% SDS-
polyacrylamide gels(6) and visualized by silver staining(?). 
Immune blots. After electrophoresis on 12% SDS-poly-
acrylamide gels, protein was electrophoretically transferred 
to nitrocellulose (Schleicher & Schuell BA85) using a Bio-Rad 
Trans-blot cell following manufacturers instructions. The 
nitrocellulose was washed twice with 0.05% Tween-20 (Sigma), 
10 mM sodium phosphate (pH 7. 0) , 0. 9% sodium chloride, then 
reacted overnight with 1% bovine serum albumin and 1% normal 
goat serum in the same buffer. After washing three times in 
buffer, 50 ml of a 1:1000 dilution of rabbit anti-B-lactamase 
was added and the membrane incubated at 37°C for 2. 5 h. 
Bound antibody was visualized using an anti-rabbit immunopep-
tide system (Vectastain ABC kit, Vector Laboratories). This 
staining procedure involves adding biotinylated goat-anti-
rabbit antibody followed by a complex composed of the multi-
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valent biotin binding protein avidin and biotinylated horse-
radish peroxidase H. After washing away unbound proteins, 
the chromogenic peroxidase substrate 4-chloro-1-naphthol is 
then added with dilute hydrogen peroxide, resulting in a 
purple spot at sites where antibody has bound. 
Ion-exchange column chromatography. Diethylaminoethyl 
cellulose (Whatman DE-52) was used in all columns. pH values 
are all measured at room temperature (22°C), even for columns 
that are run at lower temperatures. All solutions contained 
0.02 % sodium azide as a preservative. 
Gel-filtration column chromatography. All columns used 
either Ultragel AcA 54 (LKB) or Sephadex G-75 (Pharmacia). 
Results and Discussion 
All initial experiments designed to optimize expression 
and purification of pBR322 B-lactamase were done using the 
wild-type enzyme unless otherwise specified. 
Release of enzyme activity from cells. An osmotic shock 
procedure was used to simplify purification. This procedure 
produces a concentrate which is predominantly periplasmic 
proteins, thus reducing the number of cytoplasmic proteins, 
especially proteases, which would have to be removed during 
purification. Comparison of techniques for release of B-lac-
tamases from bacterial cells has indicated that osmotic shock 
preferentially releases plasmid-encoded lactamases in high 
yield(8,9). 
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By splitting a single batch of cells and comparing the 
efficacy of the osmotic shock procedure versus that of sonic-
ation, I found that the osmotic shock procedure consistently 
released 85-90 % of the amount of activity released by sonic-
ation. Since the enzyme yields were virtually identical and 
the specific activity of enzyme recovered using the osmotic 
shock procedure was much higher, all further isolations used 
this technique. As a further test for release, the cell 
pellet remaining after an osmotic shock procedure was 
sonicated. This released approximately 10 % of the amount of 
activity present in the supernatant. 
Though some authors utilize lysozyme to degrade the cell 
wall during osmotic shock procedures, I found no difference 
in yield or purity of enzyme using lysozyme digestion (50 
1-19'/ml in sucrose solution, 30 min at room temperature) as 
contrasted to the osmotic shock procedure without lysozyme 
treatment. 
One change which did improve the efficacy of the osmotic 
shock procedure was increasing the volumes of sucrose solu-
tion and distilled water used. The amount of released activ-
ity varied with the volume of sucrose solution and distilled 
water, with the amount increasing with volume until a ratio 
of 20 ml per 1 g wet cells was reached. Solution volumes 
above this ratio resulted in no further increase in released 
activity. 
The Tris-HCl wash and sucrose solutions were examined 
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for any loss of activity due to leaching in these steps. No 
activity was detected in these solutions in growths using the 
intrinsic pBR322 promoters. In growths using cells con-
taining the tac promoter in which good induction was at-
tained, some enzyme loss was detectable in these solutions. 
As this lost activity was generally small compared to the 
activity in the final osmotic shock solution, it was usually 
discarded. In the worst case of such activity loss, which 
was the best IPTG induction of the T71S mutant, 25 % of the 
total activity was found in the combined washes. 
Growth curve. In order to determine the optimal fermen-
tation time for maximizing enzyme yield, a growth curve was 
determined. At each time point, cell density was estimated 
by light scattering at 540 nm and enzyme activity was esti-
mated after cell lysis using sonication. It was found that 
enzyme yield slightly lagged behind cell number until ten 
hours after the start of fermentation (at 37°); after this 
time point, enzyme yield dropped dramatically. 
Use of inducible promoter. Though the ampr gene of 
pBR322 already contains two constitutive promoters(lO), nei-
ther of these promoters has an especially strong ribosome 
binding affinity. To increase production of mutant beta 
lactamases, a plasmid was constructed placing the strong 
hybrid promoter tac(ll) in front of the ampr gene of pBR322. 
This plasmid(pKK) was transferred into the host cell Dl210, 
which constitutively produces lac repressor(laciq), which can 
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bind to the tac sequence. This plasmid-host combination was 
used for experiments maximizing IPTG induced B-lactamase 
synthesis. 
This plasmid was useful in expressing active B-lactamase 
mutants. However, this construction interferes with the 
expression of the tetr gene. This means a pKK plasmid con-
taining an inactive B-lactamase mutant would possess no 
selectable marker. To allow this promoter to be used for the 
inactive B-lactamase mutants, the BamH1-Hindiii fragment in 
the tetr gene of pKK was replaced by a BamH1-Hindii fragment 
from pGR417 coding for resistance to kanamycin(12). This 
gene is expressed in this construction. The EcoR1-Pvu1 frag-
ment of the mutant bla genes were used to introduce the 
inactive mutants into this plasmid. 
identified by the prefix pJN. 
These plasmids are 
Induction of B-lactamase activity using the tac promo-
ter. Even without the addition of IPTG, larger amounts of 
B-lactamase were produced by plasmids containing the tac 
promoter, even in a laciq strain (Table II-2) . Addition of 
0. 1 mM IPTG resulted in a large increase in the amount of 
B-lactamase produced. However, if the cells were exposed to 
this concentration of IPTG for longer than 20-30 minutes, 
yield of enzyme began to decrease. 
Generation of specific anti-B-lactamase antibody. 
Figure II-1 shows a western blot using immune rabbit serum to 
stain purified wild-type B-lactamase, a whole cell extract 
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containing B-lactamase, and the same E.coli host cells(LSl) 
without plasmid as a control. The antibody has a high affin-
ity for wild-type B-lactamase, although contaminating 
proteins in the crude extract and proteolytic fragments cross 
react to some extent. 
Column chromatography of pBR322 B-lactamase. The origi-
nal procedure for B-lactamase purification from periplasmic 
fluid(l3) consisted of ion-exchange chromatography [DE-52,10 
mM Tris-HCl(pH 6.75)]. In our hands, this procedure was not 
successful. Recovery of enzyme activity was never higher 
than 50 % from this step and the column flow rate was very 
slow, even when large diameter ( 10 em) columns were used. 
Changing the pH of the buffer to any point between 6.5 and 
7.5, or increasing the buffer concentration to 50 mM resulted 
in no improvement. This step was eventually discarded and 
replaced with the ammonium sulfate precipitation described 
below. 
The next purification step was originally an ion-ex-
change gradient column(DE-52) using a linear gradient of pH 
7.25 triethanolamine, 15 to 100 mM. In our hands, enzyme 
activity was eluted at the very end of this gradient. 
Accordingly, this gradient was replaced with a 25 to 200 mM 
gradient of the same buffer. 
middle of this gradient. 
Active enzyme was eluted in the 
All three of the active site 
mutants showed no change in elution position on this column. 
These differences in ion-exchange behavior between the 
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pBR322 enzyme in our hands and the almost identical enzyme 
in the previously published procedure are almost certainly 
due to the known single amino acid difference between the two 
proteins. The pBR 322 (RTEM-l) enzyme possesses a Gln at 
position 37, while the RPl (RTEM-2) enzyme has a Lys at this 
position(l4,l5). This difference, originally detected by 
comparison of the DNA sequence of the pBR322 enzyme with the 
protein sequence of the RPl enzyme, has been confirmed by 
N-terminal sequencing of the purified pBR 322 protein. 
The mutant B-lactamases are temperature sensitive, but 
can be isolated. Initial attempts to isolate the active 
revertant enzyme T7lS by growing cells at 37°C yielded little 
or no activity. Cells grown at 3 0°C produced detectable 
amounts of activity, even without the use of a strong promo-
ter. Cells producing the wild-type B-lactamase showed no 
signs of decreased yield of active enzyme until temperatures 
of 42-44°C were reached. A similar increase in the yield 
of the two inactive mutants S70T and S70T-T7lS (as judged by 
SDS-PAGE quantification of B-lactamase) was found at the 
lower growth temperature. 
As shown in Chapters 3 and 4, the active revertant 
enzyme is still active at 37oC, but does denature with a 
half-life of 20-30 minutes. The periplasmic fluid of E.coli 
therefore is likely to contain proteases that amplify the 
thermal instability of this mutant. A number of protease 
inhibitors were added to the growth media in an attempt to 
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block such proteolysis. These inhibitors produced no 
increase in enzyme yield. Similarly, growth of the plasmid 
in the E.coli strain SG 4121, which is a lon- strain, 
resulted in no increase in activity. The lon locus encodes 
an ATP-dependent protease known to eliminate some defective 
proteins(l6). This protease is apparently not the one 
involved in degrading these mutant ~lactamases. 
Mutant B-lactamase stability improves when the periplas-
mic fluid is separated from the host cells. However, the 
active revertant quickly loses activity if stored in peri-
plasmic fluid. After storage at 4°C for one month, virtually 
all activity has vanished. The stability of this protein 
increases after ammonium sulfate precipitation (see below). 
This implies again that the protein is being degraded by a 
protease present in periplasmic fluid and that this protease 
is removed by the ammonium sulfate precipitation step. In 
contrast, the wild-type B-lactamase is stable for at least 
three years when stored at 4°C in E.coli periplasmic fluid. 
Ammonium sulfate precipitation. The initial ion-ex-
change column was replaced by an ammonium sulfate precipita-
tion. The periplasmic extrudate was brought to 2 o % (wjv) 
ammonium sulfate at room temperature and the precipitate was 
discarded. Sufficient solid ammonium sulfate was added to 
the supernatant to bring the concentration to 66% and the 
precipitate was collected. This precipitate contains 70 to 
100 % of the original activity and the precipitation results 
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in a specific activity increase of 7 fold. The precipitates 
were easier to collect at room temperature than at cold room 
temperature ( 4°C). No pH adjustment was necessary. The 
stability of the mutant B-lactamases improved dramatically 
after this step. The stabilization of B-lactamase by sulfate 
ions has also been seen in physical studies of B-lactamase 
denaturation(17). 
Gel-filtration column chromatography. As a final puri-
fication step the enzyme was applied to 1 by 50 em column of 
Ultragel AcA 54 and eluted with 20rnM Tris-HCl(pH 7.0). The 
literature procedure included a further purification step for 
protein that was still impure at this stage. This step 
involved chromatography on DE-52 ion exchange cellulose in 10 
mM potassium phosphate (pH 7. 0) . This DE-52 step only re-
sulted in total loss of enzyme when repeated on the pBR 322 
enzyme. Lots of pBR 322 enzyme that were not completely 
homogenous after passage over the AcA 54 column were concen-
trated and the AcA 54 step was repeated. 
Reverse-phase liquid chromatography. B-Lactamase sam-
ples were purified on a Vydac C4 column using a water-aceto-
nitrile gradient with all solutions containing 0.1 % triflor-
oacetic acid(TFA). Though pure protein was obtained, the pBR 
322 lactamase was denatured both by the acetonitrile alone as 
well as the TFA. This procedure was used as a check on the 
purity of samples used for kinetic analysis, as it often 
revealed contaminating proteins. 
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Summary of protein purification protocol. This is the 
final version of the growth and purification procedures used 
to generate the purified B-lactamase enzyme characterized in 
the remainder of this work: 
1. Fermentation of E.coli 01210 bearing plasmid containing 
mutant B-lactamase gene with tac promoter at 30°C to late log 
phase. 
2. IPTG ( o .lmM) is added, followed by rapid cooling to 
o-4°C. 
3. Cells are gathered by centrifugation, washed, and then 
suspended in hyperosmotic sucrose with EDTA. After the cells 
are reconcentrated, they are suspended in ice-cold water and 
vigouously stirred. The cells are removed and sodium azide 
is added to the supernatant(=crude enzyme). 
4. Solid ammonium sulfate(20 % wjv) is added to the crude 
enzyme and stirred at room temperature. The precipitate is 
discarded and additional solid ammonium sulfate (to 66-70 % 
wjv) is added, again followed by stirring at room tempera-
ture. The precipitate from this step is collected and dis-
solved in water. The residual ammonium sulfate is removed by 
dialysis and the enzyme solution is concentrated to a final 
volume of 25-30 rnl. 
5. The enzyme solution is applied to a 2.5 x 25 ern column of 
DE-52 equilibrated with 25 mM Triethanolarnine-HCl (pH 7.25) 
and eluted with a 25 to 200 rnM linear gradient of the same 
buffer. 
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6. The active fractions are concentrated and applied in a 
small volume (1-2 ml) to a 1 x 50 em column of Ultragel AcA 
54 and eluted with 20 mM Tris-HCl (pH 7.0). The high speci-
fic activity fractions are checked for homogeneity on 12 % 
PAGE-SDS. If impurities persist, step 6 is repeated. 
Summary 
It is possible to produce and purify active site mutant 
proteins of pBR322 B-lactamase. All active site mutants 
examined behaved as temperature sensitive mutants and were 
unstable at the normal growth temperature of 37°C. The use 
of an IPTG induced tac promoter and a lower growth tempera-
ture increased production of the unstable T71S B-lactamase 
fifty fold. The inactive mutants S70T and S70T-T71S were 
synthesized in detectable amounts, reacted with anti-B-lac-
tamase antibody, and behaved identically to the wild-type 
enzyme on SDS gels and on ion-exchange and gel filtration 
columns. 
34 
References 
1. Bryan,L.E. (1984) Antimicrobial Drug Resistance Academic 
Press, Orlando ,Florida 
2. Dalbadie-McFarland,G.,Neitzel,J., and Richards,J.H. 
(1986) Biochemistry 25, 332-338 
3. Boyer,M.W., and Roulland-Dussoix,D. (1969} J.Mol.Biol. 
41, 459-472 
4. Maniatis,T.,Fritsch,E.F. and Sambrook,J. (1982} Molecu 
lar Cloning: A Laboratory Manual Cold Spring Harbor 
Laboratories, New York 
5. Samuni, A. (1975) Anal.Biochem. Ql, 17-26 
6. Laemmli,U.K. (1970) Nature(London) 227, 680-685 
7. Merril,C.R.,Goldman.D.,Sedman,S.A., and Ebert,M.H. 
(1981} Science 211, 1437-1438 
8. Simpson,I.N. and Harper,P.B. (1981} Journal of Antimi-
crobial Chemotherapy 2, 307 
9. Simpson,I.N. and James,M. (1982) Journal of Antimi 
crobial Chemotherapy 2, 119-123 
10. Brosius,J.Cate,R.L. and Perlmutter,A.P. (1982} J.Biol. 
Chem. 257,9205-9210 
11. DeBoer,H.A., Comstock,L.J., and Vasser,M. (1983} Proc. 
Natl.Acad.Sci.USA 80, 21-25 
12. Nanoff,L. (1985} Personal communication 
13. Fisher,J.,Belasco,J.G.,Knosla,s.,and Knowles,J.R. (1980) 
Biochemistry 19, 2895-2901 
14. Sutcliffe,J.G. (1978} Proc.Natl.Acad.Sci.USA, 75, 3737-
3741 
15. Ambler,R.P. and Scott,G.K. (1978} Proc.Natl.Acad.Sci. 
USA 75, 3732-3736 
16. Chung,C.H. and Goldberg,A.L. (1981} Proc.Natl.Acad.Sci. 
USA 78,4931-4935 
17. Mitchinson,C. and Pain,R.H. (1985) J.Mol.Biol. 184, 
331-342 
Table II-1. 
sources. 
Name 
1. pBR322-22G9 
2.pBR322-997 
3.pBR322-R2 
4.pBR322-GDM* 
S.pKK 
6.pARR 
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The plasmids used in this work and their 
Comment 
S70T-T71S mutant 
S70T mutant 
Source 
1-4 from G. 
Dalbadie-McFarland 
Active revertant from 22G9, 
shown to be T71S 
C77S mutant 
tac promoter source J.Rossi 
kanamycin resistance gene L.Nanoff,Dupont 
* This mutation was also obtained from Steve Schultz. The 
proteins obtained from the two plasmids were identical. 
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Table II-2. The yield of active T71S beta-lactamase as a 
function of promoter and IPTG induction. 
Conditions Total Yield 
( I.Jkat/12 1) 
pBR 322 amp promoters 8.07 
tac promoter, 30o 
no induction ' 
87.9 
tac promoter, 30°. 451 
IPTG induced 
Specific Activity 
of Extruded Protein 
( 1.Jkat;A281 ) 
.12 
.14 
.12 
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Figure II-1. Photograph of peroxidase stained 
nitrocellulose membrane from immune blotting procedure. From 
left to right: whole cell extract of E.coli LSl containing 
pBR322; purified beta-lactamase (.2 ~g); LSl cells containg 
no plasmid. 
38 
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CHAPTER III 
THE NATURE OF THE CATALYTIC DEFECT 
IN SOME ACTIVE SITE MUTANT BETA-LACTAMASES 
40 
Introduction 
Two general mechanisms for the hydrolytic action of 
B-lactamases have been proposed(!). These enzymes could act 
as general acid-base catalysts to facilitate the direct 
attack of water on the B-lactam carbonyl. The zn2+ dependent 
type B B-lactamase uses this mechanism(2) . Alternately, B-
lactamases may provide a nucleophile to attack the B-lactam 
ring directly, leading to formation of an acyl-enzyme inter-
mediate. Evidence for this second mechanism, involving the 
use of the highly conserved Ser70 residue in the formation 
of such an acyl-enzyme intermediate in the ring cleavage 
mediated by class A and class c B-lactamases, has come from 
several sources. Initially, this residue was identified as 
beinh present in the active site by labeling with presumed 
mechanism-based inactivators such as 6-B-bromopenicillanic 
acid ( 3) . Poor substrates such as cloxacillin or cefoxitin 
have been used to identify a putative acyl-enzyme interme-
diate in a substrate cleavage reaction(4,5). In the case of 
the substrate cefoxitin it was possible to directly observe 
the formation of an ester, presumably the intermediate, by 
using FT-IR ( 5) . It was also possible to trap a covalently 
linked enzyme-substrate intermediate using 14c-cefoxitin(5). 
The alkaline lability of the enzyme-substrate complex formed 
between the s. aureus PCl enzyme and a dansyl-cephalosporin 
derivative also suggests an intermediate ester(6). 
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Mutagenic replacement of this serine residue in the 
pBR322 enzyme with a cysteine residue yields a modified yet 
active enzyme(?). The replacement of the alcohol with a 
thiol results in a protein characterized by unaltered Km 
values for benzylpenicillin and ampicillin with respect to 
the wild-type, but whose kcat values are reduced to 1-2 % of 
wild-type values for these substrates. Thio-B-lactamase also 
hydrolyzes a cephalosporin derivative(nitrocefin), but the Km 
value for this substrate is so elevated that it is difficult 
to saturate the enzyme ( 8) . This ability of thio-Blactamase 
to retain hydrolytic activity for normal amide substrates is 
in marked contrast to the case in serine proteases, where 
replacement of the active site serine hydroxyl by a thiol 
results in the loss of amidase activity, whereas some degree 
of esterase activity remains(9). 
One of the major problems that has hampered the study of 
the hydrolytic mechanism of B-lactamase is the rapid rate at 
which good substrates are turned over. For example, 
benzylpenicillin(Penicillin G) is hydrolyzed by the RTEM 
'th k /K f 108 M-1s-1. enzyme WJ. a cat m o over For this reason, 
most detailed kinetic information about the class A B-lactam-
ases has been obtained using poor substrates, which are more 
slowly hydrolyzed. It is possible that the mechanism by 
which good substrates react may differ from the mechanism 
observed when poor substrates such as cefoxi tin are exam-
ined. For example, the Bacillus cereus type I enzyme readily 
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hydrolyzes penicillins and cephalothin, but appears not to 
bind, and thus poorly cleaves, cefoxitin(10). 
In spite of a vast number of protein modification exper-
iments(reviewed in reference 11), evidence for the involve-
ment of amino acids other than Ser70 in the hydrolyis of 
B-lactams is sparse. Lys73 is a highly conserved residue in 
class A and C B-lactamases and all other penicillin binding 
proteins. Site-saturation of the pBR322 enzyme at this 
position has revealed that this residue is essential for 
catalysis and cannot be replaced by any other naturally 
occurring amino acid(12). Chemical modification experiments 
using phenylpropynal have shown that the reaction of this 
compound with a nucleophile present in B-lactamase inactiv-
ates this enzyme while generating a chromophore whose spec-
tral properties are consistent with reaction with lysine or 
arginine(13). Lys73 is a logical candidate as the reactive 
group. In addition, mechanism-based inactivators such as 
penicillanic acid sulfones ( 14) , clavulanic acid ( 15, 16) , and 
6-acetylmethylenepenicillanic acid(17) appear to partition at 
the acyl-enzyme intermediate step, with a fraction of the 
intermediate reacting with an internal nucleophile to form an 
inactive modified enzyme. Low-resolution X-ray structures of 
B-lactamase and other penicillin binding proteins place this 
lysine residue very close to the bound substrate, making this 
amino acid the only other irreplaceable residue in B-lactam-
ase(18). 
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A mechanism that accounts for most of the kinetic data 
available for the B-lactamase promoted hydrolysis of penicil-
lins is given in equation III-1: 
k1 k2 
(III-1) E + S ... E·S )IIJr E-P--~)IIJr~E + P 
k_1 
The initial formation of the enzyme-substrate complex (E · s) 
appears to be very rapid. In the case of the Bacillus cereus 
B-lactamase I there is evidence that the reaction with good 
substrates is diffusion controlled ( 19) . By comparison, the 
hydrolysis of the sluggish substrate cephalothin (kcat/Km = 
104 M-1s-l) shows no change with variations in viscosity 
(changed by adding sucrose), indicating that diffusion is not 
a rate limiting step for this substrate. Quantitative analy-
sis of the "on-rate" constants (k1 ) shows that this constant 
does not substantially differ for a wide variety of sub-
strates. The variation in kcat values for various substrates 
is primarily due to changes in the partition ratios, k_1;k2 , 
for the various ES complexes. This variation appears to be 
due to differences in substrate-enzyme interaction, as the 
rate constants for the non-enzymatic second-order base-cata-
lyzed ring opening reaction do not significantly differ for a 
wide variety of penicillins and cephalosporins (20,21). 
The substantial decrease in free energy upon cleavage of the 
B-lactam ring in forming the acyl-enzyme intermediate makes 
it unlikely that this step is reversible. 
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After the acyl-enzyme intermediate, (E-P), is formed 
the simplifying assumption that deacylation is irreversible 
is also well justified. The Km for penicillinate has been 
measured and is more than an order of magnitude larger than 
that observed for penicillins {22). As all kinetic observa-
tions desribed herein have been done under conditions where 
product concentration are small relative to substrate concen-
tration, this back reaction can be safely ignored. 
The mechanism for cephalosporin hydrolysis appears to be 
more complicated than that seen for penicillin hydrolysis. 
In the hydrolysis of cefoxitin by RTEM B-lactamase a good 
leaving group{3'carbamoyloxy) can be released from the cepha-
losporin acyl-enzyme intermediate before deacylation takes 
place, leading to a partioning of the initial acyl-enzyme 
intermediate between hydrolysis, regenerating free enzyme, 
and the elimination reaction, yielding a second acyl-enzyme 
intermediate, which can then hydrolyze, also regenerating 
free enzyme(23). This branched pathway is illustrated in 
Figure III-1. In addition, observation of the hydrolysis of 
dansyl-cephalexin has revealed the existence of a kinetic 
intermediate prior to the formation of the acyl-enzyme inter-
mediate(6). This may be a tetrahedral adduct formed prior to 
the acyl-enzyme. 
Penicillin binding proteins and B-lactamases can be 
viewed as following similar mechanistic pathways. Once an 
acyl-enzyme intermediate is formed, however, the two classes 
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of protein differ. While the B-lactamases readily deacylate, 
generating a free penicillinate, the acyl-enzyme forms of the 
penicillin binding proteins have very long lifetimes. The 
penicillin is not released from a penicillin binding protein 
as penicillinate, but rather the thiazolidine ring fragments 
into at least two major components, for example, yielding the 
fragments N-phenylacetylglycine and N-formyl-D-penicillamine 
when benzylpenicillin is the original antibiotic(24). 
The experiments desribed in this chapter are aimed at 
determining which step or steps in the catalytic hydrolysis 
B-lactams are crippled in three purified mutant B-lactamase. 
The enzymes studied include two with an inactive phenotype-
(S70T-T70S and S70T) and an active revertant enzyme(T70S). 
Materials and Methods 
Materials. Sodium cefoxitin(Mefoxin) was a generous gift of 
Merck Sharp and Dohme. 35s-benzylpenicillin was obtained 
from New England Nuclear Research Products. All other anti-
biotic substrates were from Sigma. All protein preparations 
used for the kinetic determinations was homogenous by SDSPAGE 
and purified according to the procedures given in Chapter 2. 
Protein concentrations were estimated by measuring the 
absorbance of stock solutions at 281 nm and using published 
conversion factors(S). 
Determination of kcat and Km· All measurements were done at 
300 c in 0.1 M potassium phosphate, pH 7.0, utilizing a Beck-
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man Acta CIII UV-visible recording spectrophotometer with 
1-cm path-length cells. For observations of cefoxitin cleav-
age at high absorbance values, a Beckman DU 7 spectrophotome-
ter with a 1 mm path length cell was used. Hydrolytic clea-
vage of benzylpenicillin was observed at 240 nm, cleavage of 
cephalothin was observed at 260 nm, and cleavage of cefoxitin 
was observed at 261 nm. The .dE values used were 500 M-1cm-1 
for benzylpenicllin(25), 7700 M-1cm-1 for cephalothin(5), and 
7775 M-1cm-1 for cefoxitin(5). Comparison of initial and 
final absorbances after complete reaction at these wavelenths 
confirmed the .d :E values. 
Determination of inhibition constant for borate. The ability 
of sodium borate to inhibit the enzymatic cleavage of benzyl 
penicillin was determined at 30°c in 0.1 M potassium phosp-
hate, pH 7. o. Substrate concentration was 0.1-1 mM and 
borate concentration was varied from 32-174 mM. 
Determination of kcat as a function of temperature. Purified 
enzyme was added to 1 mM benzylpenicillin in 0.1 M potassium 
phosphate, pH 7. 0, preheated to the desired assay tempera-
ture. Activity was measured during the initial linear phase 
of the hydrolytic reaction. 
Observation of pre-steady state burst. The measurement of 
the pre-steady state burst rate was made as previously des-
cribed ( 4). To a 10. o mm path-length cuvette was added a 
solution of enzyme in 0.1 M potassium phosphate buffer, pH 
7. o. The reaction was initiated by addition of cefoxi tin. 
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An optical quartz block was quickly inserted to shorten the 
path-length to 1. o nun. The progress of the reaction was 
observed at 261 nm using a Beckman DU-7 spectrophotometer 
with the cuvette temperature maintained at 30° c. The change 
in absorbance due to mixing was determined by repeating the 
procedure in the absence of enzyme and was subtracted from 
the observed kinetic data. The rate constant(kobs) and burst 
size(n/e0 ) were determined by applying the double Guggenheim 
method(26). For the inactive mutants, a similar procedure 
was used to measure possible acylation of enzyme, as this 
would result in opening of the B-lactam ring of cefoxitin 
with a resulting change in absorbance at 261 nm. 
Active site titration. The magnitude of the pre-steady 
state burst(nje0 ) seen at 261 nm upon the addition of cefoxi-
tin was measured as a function of enzyme concentration for 
both the wild-type and the active revertant B-lactamase. The 
conditions used were the same as those described above. 
Direct observation of deacylation rate. Purified enzyme 
(wild-type or active revertant, 0.19 nmole) was incubated at 
3 0° c with cefoxi tin ( 16.2 mM) • An aliquot of this mixture 
was then added to 1 mM benzylpenicillin, 0.1 M potassium 
phosphate, pH 7.0, and the change in A240 observed at 30°C 
using a Beckman DU-7 spectrophotometer with 1-cm path 
length. 
Isolation of acyl-enzyme. Mutant enzyme was incubated 
with 35s-benzylpenicillin or 14c-cefoxitin in 0.1 M phosphate 
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buffer, pH 7.0. After incubation, the mixture was applied to 
a Sephadex G-25 column(l by 20 em) and eluted with the same 
phosphate buffer. Twenty drop fractions were collected. 
Aliquots of each fraction were assayed for radioactivity by 
scintillation counting. Protein was estimated in each frac-
tion by absorbance at 281 nm. Figure III-2 shows a typical 
column profile for such an experiment. This procedure was 
repeated with bovine serum albumin as a control. 
Equilibrium dialysis. All solutions used were buffered 
by 0.1 M potassium phosphate, pH 7.0. Protein and substrate 
compartments were separated by a presoaked membrane(Specktra-
phor 1, molecular weight cutoff 6-8,000). Mutant B-lacta-
mases were present at 0. 3 06 mgjml ( 11. 3 IJM) . Ligand was 
35s-benzylpenicillin (3. 8 Cijmmol) diluted with fresh unla-
beled sodium benzylpenicillin to a specific activity of 38 
mCijmmol. Substrate concentrations ranged from 100 IJM to 415 
IJM with duplicate runs done at each concentration. All 
experiments were done at a temperature of 30° c and the 
dialysis compartments were shaken during incubation. At the 
end of the incubation period, 20 IJl was removed from each 
compartment and assayed for 35s counts after dilution to 1 ml 
and addition of 10 ml scintillation fluid. Final volumes of 
each compartment were also measured. A control well con-
taining only ligand on one side was run with each experiment 
as a check to insure that equilibrium had been reached. 
Also, the A281 of each ligand compartment was measured as a 
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control for protein leakage due to a damaged membrane. 
Control wells showed less than 8 % leakage of material absor-
bing at 281 nm after 24 hours shaking at 30° c. 
Results and Discussion 
Kinetic parameters of active revertant. Kinetic parame-
ters were obtained from single reaction progress curves. 
Multiple initial substrate concentrations (ranging from 100 
to 500 M for benzylpenicillin) were used as a controls for 
product inhibition. As this reaction is not readily reversi-
ble, it is possible to use any of the standard linear plots, 
such as Lineweaver-Burk, to determine kcat and Km even if the 
reaction extent is large, provided that [S] (the average 
substrate concentration for each time range) rather than [S]o 
is used as the horizontal axis variable(27). Table III-1 
collects the appropriate kinetic parameters for the cataly-
tically active T71S mutant for benzylpenicillin and cepha-
lothin, while Table III-2 presents these data for cefoxitin. 
Also included for comparison are the values for the other 
known active site mutant thiolactamase S70C (8). The rela-
tive activities towards penicillin and cephalosporin are also 
shown. In the case of all of the substrates examined, no 
significant difference relative to the wild-type value was 
found for the Km values for the active revertant, while all 
kcat values for this enzyme were dramatically reduced. The 
kcat values were approximately 15 % of the wild-type value 
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for benzylpenicillin and cephalothin and 8 % of wild-type for 
cefoxitin. The observation that the Km values are unchanged 
and kcat values are reduced is consistent with the active 
revertant enzyme binding substrate and acylating at the same 
rate as wild-type enzyme, but possessing a defect in its 
deacylation ability. As the cefoxitin acyl-enzyme intermedi-
ate is known to deacylate poorly even in the wild-type en-
zyme, this may explain the greater rate reduction (relative 
to wild-type) seen for cefoxitin hydrolysis by active rever-
tant enzyme compared to the rate reductions seen for hydroly-
sis of other substrates by this active mutant enzyme. More 
direct evidence for the relative participation of changes in 
acylation and deacylation abilities are presented below. No 
increase in the rate of enzymatic hydrolysis of cefoxitin is 
seen upon addition of an exogenous nucleophile(hydroxyl-
amine,48 mM) to either wildtype(4) or active revertant B-lac-
tamase. This suggests that the acylenzyme intermediate in 
the revertant B-lactamase is still shielded from external 
nucleophiles. 
The ratio of kcat/Km is the apparent second-order rate 
constant for the conversion of free enzyme plus substrate to 
free enzyme plus product. 
to the activation energy, 
The log(kcat/Km) is proportional 
:f-~GT(28). The difference between 
transition state binding energies for two proteins assayed 
against the same substrate can be calculated from equation 
III-2(29): 
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(III-2) 
Using this equation, the change in the transition state 
binding energy for the enzymatic hydrolysis of benzylpenicil-
lin and cephalothin by the T71S mutant of B-lactamase can be 
estimated. The transition state binding energy for benzyl-
penicillin has been elevated by 945 calories relative to the 
wild-type enzyme, while the transition state for cephalothin 
hydrolysis has been raised by 1340 calories. This activation 
:f 
energy, fl. ~T 
positive term 
is the sum of two factors-an algebraically 
-t ll.G, the activation energy of bond rearrange-
ments, and an algebraically negative term1 ll Gs ,the substrate 
binding energy. In the T71S B-lactamase, either the activa-
tion energy term ll.Gfhas been elevated relative to the wild-
type enzyme, or the negative binding energy termll.Gs has been 
made less negative. (Of course, a combination of both of 
these two changes may have occured). In the Michaelis-Menton 
mechanism, Km is a function of 4. Gs. Since the Km values for 
cleavage of B-lactams by the T71S enzyme are unaltered, one 
can conclude that ll.Gs is unchanged and that the increase is 
in the activation energy for this reaction is due to an 
t increase in fl. G, the energy involved in the making and break-
ing of bonds necessary in reaching the transition state from 
the initial ES complex. 
Purified active revertant enzyme is also capable of 
cleaving methicillin, ampicillin, and cephalosporin c, but a 
detailed kinetic analysis was not performed on these sub-
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strates. This result is consistent with earlier phenotypic 
studies of this mutant, which showed that this mutant gave 
resistance to all penicillins tested, and gave slight resis-
tance to cephalosporins. 
Boric acid is one of the best known competitive inhibi-
tors of RTEM B-lactamase. The ability of boric acid to serve 
as a competitive inhibitor of benzylpenicillin was examined 
in the active revertant enzyme. The Kr for borate inhibition 
was unchanged from that seen in wild-type enzyme (Table 
III-3). This suggests that the hydroxyl groups of either a 
threonine or serine residue at position 71 interacts equally 
well with boric acid, or that the only interaction of this 
inhibitor is with the active site serine 70. Thiolactamase(-
Ser70 to Cys) is not inhibited by borate(S), supporting the 
second possibility. 
Activity as a function of temperature. The results of 
activity measurements made at elevated temperature are shown 
in Figure III-3. In the temperature range of 30 to 45°C the 
ratio of activity of the active revertant relative to wild 
type increases compared to the value of this ratio at 30°C. 
This activity increase is due to an increase in the value of 
kcat· Above 45°C, it was impossible to accurately measure 
initial activity, as thermal denaturation of the mutant 
enzyme occured on the same time scale as the activity mea-
surements . The altered stabilities of the mutant B-lactam-
ases are examined in more detail in Chapter 4. 
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Activity as a function of pH. No differences in activi-
ty as a function of pH were found between the active rever-
tant enzyme and wild-type B-lactamase in the pH range 4.0 to 
8.0. Above this pH both enzymes rapidly denatured. 
Active site titration. The reduction in kcat seen for 
hydrolysis by the active revertant could be due either to a 
reduction of the intrinsic ability of each catalytic site to 
cleave a B-lactam bond or it may be due to a decreased number 
of active sites in the revertant enzyme, with each one of 
these sites possessing normal catalytic ability(30). To 
distinguish between these possibilities, it is necessary to 
measure the number of functional catalytic sites independent 
of protein concentration. The number of active sites in 
- ·- .. . - - --- - - -- - - -- -
B-lactamase can be measured using the poor substrate cefoxi-
tin. This substrate acylates rapidly relative to deacylation 
with an easily observed decrease in UV absorbance. Measure-
ment of the size of the initial rapid burst and plotting this 
magnitude relative to amount of protein added allows determ-
ination of the number of active sites per unit of protein. 
Based on this procedure, the active revertant enzyme has 
nearly as many active sites per mg of protein as the wild-type 
enzyme possesses. The active revertant has 88+9 % of the 
number of active sites the wild-type enzyme has, far larger 
than the reduction in kcat (8-15 % of wild-type, depending on 
the substrate) . This reduction in kcat thus cannot be solely 
due to a reduction in number of normal catalytic sites. 
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However, this procedure can not detect a reduction in number 
of sites capable of deacylation. As seen below, after 
sufficient time the transiently inactivated acyJ enzyme 
regains its initial level of activity against benzyl-
penicillin, ruling out the inability of revertant enzyme 
active sites to deacylate as the cause for the diminished 
reaction rate. 
Observation of pre-steady state burst. The active 
revertant enzyme shows no significant difference in burst 
size(n/e0 ) or rate constant(kobs> when compared with the 
wild-type enzyme(Figures III-4,5; Table III-2 ). This indi-
cates that decrease in the acylation rate(k2 ) is not the main 
cause for the lowered kcat seen for the active revertant 
enzyme and suggests that the lowering of the steady-state 
hydrolysis rate is predominantly due to a decrease in deacyl-
ation rate (k3 ). 
Direct observation of deacylation rate. The deacylation 
rate for cefoxitin was also directly measured. By incubating 
enzyme at a cefoxitin concentration much higher than the Km 
for this substrate, most of the enzyme was converted into the 
acyl-enzyme form. This transiently inactivated enzyme was 
then diluted into a larger volume of a good substrate(such as 
benzylpenicillin) at a high concentration relative to its Km, 
resulting in the cefoxitin concentration being reduced below 
its Km· As the enzyme deacylates, it is much more likely to 
react with the large excess of good substrate molecules 
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present. By observing the increase in ability to hydrolyze 
benzylpenicillin with time by a ~-lactamase sample previously 
incubated with cefoxitin, the deacylation rates for wild-type 
and active revertant enzymes were determined. After suffi-
cient incubation time, the cefoxitin treated enzyme (both 
wild-type and active revertant) reattained control levels of 
benzylpenicillin cleaving ability. 
The deacylation rate for the active revertant enzyme is 
dramatically reduced relative to the wild-type enzyme (Table 
III-2) • This reduction, to about 8 % of the wild-type 
value, corresponds well to the rate reduction seen for cefox-
itin hydrolysis by this enzyme, adding further support to the 
hypothesis that the deacylation rate is the limiting step for 
hydrolyis of this substrate. 
The observed deacylation rate reduction could be due to 
an inability of the nucleophile responsible for deacylation 
to properly interact with the acyl-enzyme intermediate. The 
methyl group missing in the Thr71 to Ser active revertant may 
provide an interaction that correctly orients this nucleo-
phile, or it may generally stabilize the enzyme and prevent 
bulky substrates(such as cefoxitin) from severely distorting 
the enzyme conformation when the acyl-enzyme intermediate is 
formed. The ability of cefoxitin to induce structural per-
turbations in an RTEM B-lactamase has been demonstrated using 
sensitivity to trypsin digestion as a probe(31) 
The inactive B-lactamase mutants do not form an acyl-en-
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zyrne intermediate. No evidence for formation of acyl-enzyme 
intermediate in B-lactam hydrolysis by the two inactive 
mutant enzymes(S70T-T71S and S70T) was found in two different 
kinds of experiment. A typical spectrophotometric experi-
ment, designed to measure formation of acyl-enzyme by mea-
suring ring opening of cefoxi tin ( similar to the procedure 
described above to measure the presteady state burst) is 
shown in Figure III-6. The absorbance change at 261 nm was 
not significantly different than the change seen due to 
mixing upon adding buffer with no enzyme. Due to the size of 
this mixing artifact, it was impossible to rule out low 
levels of acyl-enzyme formation using this procedure alone. 
However, it was possible to assign an upper limit of 10 % of 
theoretical acylation, assuming all protein was folded in a 
native conformation and that denaturation had not taken place 
during purification or storage. It should be noted that the 
inactive mutants were presumed to be temperature-sensitive. 
They were produced at low temperature ( 3 o0 c) and were kept 
cold at all times during purification to minimize thermal and 
proteolytic degradation. 
As a more sensitive probe of acyl-enzyme formation, the 
mutant proteins were reacted with radiolabelled substrate, 
and then enzyme-bound substrate was separated from unbound 
substrate by gel filtration. Using both a poor substrate 
cl4_c-cefoxitin) and a good substrate c35_s-benzylpenicil-
lin), no covalent enzyme-substrate intermediate formation was 
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detected beyond a low background of 0. 02 % of theoretical. 
This background was similar in magnitude to the slight amount 
of non-specific binding seen for benzylpenicillin binding to 
a presumably nonspecific protein such as bovine serum albu-
min. This background value is presumably due to the high 
reactivity of the B-lactam ring, which can randomly react 
with any surface nucleophile of a protein. These nonspecific 
covalent linkages are believed to be responsible for 
producing the epitopes involved in the allergic response to 
penicillin(32). 
Incubation times in the radiolabeling experiments ranged 
from 30 minutes to 12 hours, with no difference in the extent 
of substrate binding detected. This result indicates that 
even very slow acylation is not occurring in the inactive 
mutant enzymes. 
Ability of the inactive .B-lactamase mutants to bind 
substrate. Though neither of the inactive mutants were 
observed to form an acyl-enzyme intermediate, they were 
examined for ability to bind substrate non-covalently. It 
should be noted that even if these proteins show some affini-
ty for a substrate such as benzylpenicillin, it cannot be 
assured that the substrate is binding at the correct location 
or in the proper configuration which would allow enzymatic 
catalysis as in an active protein. In addition, due to the 
speed with which the active proteins cleave a good substrate 
such as benzylpenicillin, it is difficult to estimate the 
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value for Ks (the substrate binding constant, k_1;k1 ) for 
these active proteins. Scatchard plots(33) of benzylpenicil-
lin binding to the two inactive mutants showed binding sites 
with an average affinity of 100-200 M were present. The Km 
for this substrate reacting with native wild-type enzyme is 
approximately 20-30 1J M. If this Km value is used as an 
estimate for the Ks value of the active enzyme, than the 
inactive mutants show about a six-fold decrease in binding 
ability. No significant difference in substrate binding was 
seen between the thr-thr and thr-ser enzymes. 
Summary 
The active revertant enzyme shows no differences in its 
substrate specificity or Km relative to the wild-type enzyme. 
However, this enzyme does have a reduced kcat value for all 
substrates, which is predominantly due to a decrease in the 
rate of deacylation. The inactive mutants(S70T-T71S and 
S70T) do not form an acyl-enzyme intermediate, but do bind 
substrate. Thus they are defective at the acylation step. 
These results show that only a primary nucleophile(either OH 
or SH) at position 70 of B-lactamase allows formation of an 
acylenzyme intermediate. A secondary nucleophile, such as 
the hydroxyl of threonine, or a primary nucleophile in the 
adjacent position in the primary protein sequence, is not an 
adequate substitute. 
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Table III-1. Comparison of Catalytic Parameters of Wild-
Type and Active Revertant ~Lactamases 
Penicillin G 
Km(lJM) -1 kcat(sec ) (kcat/Km)(M-1sec -1) 
Ser Thr ( W ild-'I'ype) 26±10 2000 ± 200 7.7x107 
Ser Ser 21±8 330 ± 100 1.6 X 107 
Cys Thr (Sigal et al.) 60±10 20 3.3 X 105 
Cephalosporins 
Km(l!M) .:..1 kcat (sec ) (kcat/Km) (M-1sec -1) 
Ser Thr (Wild-Type) 250 ± 100 230± 50 9.2x105 
(Cephalothin) 
Ser Ser (Cephalothin) 300 ± 100 30±10 1 X 105 
Cys Thr (Sigal et al.) 1800 (1000) 2 (1700) 1.1 X 103 
(Cephaloridine, wild-type (1.7x106) 
value in brackets) 
Penicillin G/Cephalosporin 
Km kcat kcat/Km 
Ser Thr (Wild-Type) 0.10 8.7 84 
(Penicillin G/Cephalothin) 
Ser Ser (Penicillin G/ 0.07 11.0 160 
Cephalothin) 
Cys Thr (Sigal et al.) 0.03 (0.05) 0.1 (1) 300 
(Penicillin G/Cephaloridine) 
63 
Table ill-2. Comparison of catalytic parameters for the cleavage of cefoxitin by 
wild-type and active revertant S-lactamase. Literature values are from (5). 
A. Steady-State Parameters 
Kcat (s-1) 
Km(mM) 
Wild-type 
observed 
3.46 X 10-3 
0.70 
B. Pre-Steady-State Burst 
Kobs (s-1) 
niEo 
1.28 ± .12 X 10-2 
0.82 
C. Deacylation Rate 
K3 (s-1) 2.9 X 10-3 
literature 
4.0 X 10-3 
0.65 
1.6 X 10-2 
0.34-0.50 
4.8 X 10-3 
T71Smutant 
3.4 X 10-4 
0.78 
1.01 ± .07 X 10-2 
0.79 
2.8 X 10-4 
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Table III-3. Constants for borate inhibition of benzylpenicillin hydrolysis by 8-
lactamases. 
Protein 
wild-type 
active revertant (T71S) 
1.02 ± .42 mM 
0.93 ± .47mM 
Values are calculated assuming purely competitive inhibition and a benzyl-
penicillin Km value of24 J.IM. 
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Figure III-1 
The reaction pathway used in the cleavage of cefoxitin 
(1) by RTEM beta-lactamase (EOH). The cefoxityl acyl-enzyme 
(4) can either deacylate, regenerating free enzyme followed 
by the breakdown of the unstable cephalosporanate (2), or 
the 3' leaving group (X-) can be released before 
deacylation. 
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EOH + 1 ~)y:~ _x ~);(~ + H' 
E 1
2
- "'-"'" E 1
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-~ 
+ x-
4 5 
I + H+ + x- - 2 + EOH I + EOH 
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Figure III-2. Column profile showing elution of S70T-T71S 
mutant B-lactamase from a gel filtration column after incu-
bation with 35s-labeled benzylpenicillin. Filled circles 
are cpm radioactivity, open circles are protein as measured 
by absorbance at 281 nm. 
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Figure III-3. The variation in the rate of benzylpenicillin 
hydrolysis with temperature for wild-type and T71S mutant 
beta-lactamase. 
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Figure III-4. Hydrolysis of cefoxitin catalyzed by the wild-
type pBR 322 beta-lactamase. The arrow on the ordinate 
shows the size of the burst. The dashed line is the 
extrapolated steady-state rate. 
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Figure III-5. Hydrolysis of cefoxitin catalyzed by the T71S 
active revertant beta-lactamase. The arrow on the ordinate 
shows the size of the pre-steady-state burst. The dashed 
line is the extrapolated steady-state rate. 
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Figure III-6. Lack of hydrolysis of cefoxitin by the S70T-
T71S double mutant of beta-lactamase. The change in OD in 
the first seconds is the same magnitude as that observed if 
no enzyme is present in the cuvette when substrate is added. 
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CHAPTER IV 
INVESTIGATION OF THE STABILITY OF 
ACTIVE-SITE MUTANTS OF BETA-LACTAMASE 
78 
Introduction 
The inability to isolate the active site mutants of 
beta-lactamase (S70T, T71S,S70T-T71S) at 37°c suggested that 
these proteins were less stable than the wild-type enzyme. 
This temperature sensitive phenotype could arise in two ways. 
First, the enzyme may not be synthesized or secreted normal-
ly. Second, the enzyme may be synthesized normally, but may 
be rapidly denatured after synthesis and export to the peri-
plasm. As reported previously, the pulse-chase studies used 
to measure the secretion of these mutants indicate that 
protein synthesis is normal for these mutants and suggests 
that these mutant proteins are denatured after secretion(l) 
The denaturation of a mutant protein can be due to thermal 
instability(2,3), instability due to the presence of chemical 
denaturants such as urea, and sensitivity to proteolysis(4). 
It should be noted that many mutant proteins are more stable 
than their wild-type counterparts(5-7). The inactivation of 
the active-site mutant beta lactamase by these processes was 
investigated and the results are presented in this chapter. 
In order to interpret these results, it is first necessary to 
review previous studies that have examined the denaturation 
of beta-lactamases and the stability of other specifically 
mutated proteins. 
Plasmid encoded beta-lactamases have been the subjects 
of a number of studies aimed at understanding protein folding 
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and denaturation. In particular, the Staph.aureus PCl and 
B.cereus enzymes have been studied by direct physical 
techniques, such as circular dichroism(8,9), proton NMR(lO), 
ultraviolet and flouresent spectroscopy(ll), and differential 
scanning calorimetry(l2). 
The following simple model has proven adequate to ex-
plain the conformational changes seen in beta-lactamases when 
they are perturbed by heat or chemical denaturants(l3): 
kl k3 
EN 
... 
Eo • X ... ..... 
k2 k4 
EN = native state Eo = reversibly unfolded state 
X = irreversibly denatured state, where k 4 is so slow as to 
be discounted 
Proline isomerization has been ruled out as a step in the 
folding or unfolding of plasmid-encoded beta-lactamases(l4). 
It is important to note that lessons learned concerning 
the stability of one of the beta-lactamases may not be true 
for other beta-lactamases. For example, a threonine to 
isoleucine mutation in the PCl enzyme causes a folding block 
that results in a completely inactive enzyme(l5). The same 
mutation at the homologous position in the pBR 322 enzyme 
(residue 71) produces one of the most stable active mutations 
of this enzyme(l6). 
The effects of single amino acid changes on the folding 
and stability of a number of proteins have been studied. The 
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best characterized of these proteins is hemoglobin, in which 
73 unstable variants have been isolated. The causes of the 
instability in these variant hemoglobins have been divided 
into nine subsets(l7). The changes produced by single amino 
acid substitutions that result in unstable hemoglobin mole-
cules include loss of a non-polar side chain, loss of a 
hydrogen bond, introduction of an interior dipole, and the 
replacement of a residue by a larger or smaller amino acid. 
Serine and threonine only differ in that threonine 
possess an additional methyl group. This single amino acid 
substitution could produce any of the above-mentioned struc-
tural effects, either directly due to the presence of the 
methyl group or by the methyl group influencing the orienta-
tion of the hydroxyl group, causing changes in internal 
hydrogen bonding. 
Another protein in which single amino acid substitutions 
have altered stability is the a subunit of tryptophan synthe-
tase from E.coli. In this case, the stability of the enzyme 
correlates well with the hydrophobicity of the substituting 
amino acid residues(6,18). 
When the amino acid sequences of three proteins ( ferre-
doxin, lactate dehydrogenase, and D-glyceraldehyde 3-phos-
phate dehydrogenase) from many species of mesophilic and 
thermophylic organisms are compared the following substi tu-
tions are frequent(with the second member of each pair pre-
sent in the thermophile):Gly to Ala, Ser to Ala, Ser to Thr, 
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Lys to Arg, and Asp to Glu(l8). 
Limited proteolysis has proven 
for detecting conformational changes 
to be a useful technique 
in proteins(l9). The 
native form of many proteins is resistant to proteolysis and 
denaturants accelerate the protease reaction. For example, 
the heat-sensitive form of E.coli adenylate cyclase is rea-
dily inactivated by proteases at slightly elevated tempera-
tures(4). This has led to the hypothesis the the unfolded 
form of a protein is the substrate for proteases, allowing 
proteolysis to serve as a probe for the conformational tran-
sition between native and unfolded states. In the case of 
ten different cytochrome c proteins, the proteolytic suscep-
tibility of these proteins to four different proteases corre-
lated well with the thermal stability of these proteins as 
measured by circular dicroism(20). A similar correlation 
between proteolytic sensitivity and denaturation as measured 
by circular dichroism is seen in mutants of the phage lambda 
repressor(21). As will be shown below, the wild-type pBr 322 
beta-lactamase also shows a similar correlation in its ther-
mal denaturation, as measured by circular dichroism, loss of 
enzymatic activity, and sensitivity to proteolysis. 
Materials and Methods 
Materials. The protein preparations used were purified 
using the procedures in Chapter 2. Thermolysin (Protease 
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type X from Bacillus thermoproteolyticus rokko) and TPCK-
(N-tosyl-L-phenylalanine chloromethyl ketone)treated trypsin 
were from Sigma. 
Thermal stability. Purified B-lactamase ( 0.1 mgjml in 
0.1 M potssium phosphate, pH 7.0) was incubated at the indi-
cated temperatures. After the various times indicated, 
samples were removed and immediately assayed at 3 o0 c for 
remaining activity with benzylpenicillin as substrate. 
Thermolysin digestion. Thermolysin (0.2 mg) was added 
to 2 ml of B-lactamase solution (0.6 mg of B-lactamase, 2 mM 
calcium acetate, and 0.1 M Tris-HCl, pH 7. 0) , and the mix-
tures were incubated at the indicated temperature. After 
appropriate intervals, aliquots were removed and rapidly 
quenched by adding EDTA (pH 7. 5) to a final concntration of 
0.01 M and cooling on ice. Aliquots 
maining B-lactamase activity at 30°C. 
were assayed for re-
This procedure was 
repeated using TPCK-treated trypsin in place of thermolysin. 
Half-lives for activity loss were estimated by plotting 
log(residual activity/initial activity) versus time. 
Resistance to cellular proteases. E.coli LSl cells 
harboring pBR322 (wild-type or active-site mutants) were 
grown in L broth with 25 IJgjml tetracycline at 37°C with 
vigorous shaking. Samples (1.5 ml) were taken at late log 
phase (Asso=l.l-1.2) and 12 hours later. Cells were pelleted 
in a Microfuge, resuspended in 50 1J 1 of gel-loading buffer 
(0.063 M Tris-HCl, pH 6.8; 2% SDS; 5% vjv B-mercaptoethanol), 
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and boiled 10 min. Aliquots of supernatant (20 !Jl) were 
analyzed by immune blotting (p.21). Resistance to periplas-
mic proteases was 
osmotic extrudate 
estimated by incubating B-lactamase in 
obtained from E.coli and assaying for 
residual activity at appropriate time points. 
Stability in urea. The enzymatic activities towards 
benzylpenicillin of the wild-type enzyme and the T71S mutant 
were determined in the presence of various concentrations of 
urea in 0.1 M potassium phosphate, pH 7.0, at 30°C and at 
protein concentrations of 0.1 mgjml or below. The proteins 
were also assayed for residual activity after storage in 0.1 
M potassium phosphate, pH 7.0 with urea added. 
Circular Dichroism and Flouresence Spectroscopy. 
Purified protein was furnished to the laboratory of Dr. A.R. 
Fink, uc Santa Cruz. 
Results 
Thermal behavior. Table IV-1 summarizes the relative 
thermal stability of wild-type and active revertant (T71S) 
enzymes as measured by catalytic activity; whereas the parent 
enzyme is stable for periods longer than 30 min at 50°C, the 
T71S mutant permanently loses activity at this temperature in 
less than 1 min. This thermal denaturation appears to be 
concentration dependent; more dilute solutions are more 
resistant to denaturation. This concentration dependence 
suggests that aggregation of thermally unfolded B-lactamase 
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is a component of this irreversible denaturation. In addi-
tion, the chemically unfolded form of the S.aureus B-lactam-
ase(9) and the thermally denatured B.cereus I lactamase(22) 
also show concentration dependent irreversible aggregation. 
Similar concentration dependent thermal denaturation is seen 
for the lambda repressor(20). The thermally denatured 
lactamase shows no change in mobility on 12 % SDS-PAGE. Even 
at 4°C, purified T71S enzyme in 20 mM Tris-HCl, pH 7.0, and 
at protein concentrations of 0.1 mgjml or above was not 
stable and became inactivated over several weeks, again with 
no change in mobility on SDS-PAGE. This would appear to rule 
out autolysis as the cause for this loss of activity. 
The circular dichroism of the wild-type enzyme as a 
function of temperature was observed; the enzyme shows a 
cooperative melting in the same temperature range in which 
enzymatic activity is lost (Figure IV-1). Circular dichroism 
changes at this wavelength (220 nm) are due to local changes 
in the backbone structure of the protein. This cooperative 
melting transition is consistent with the results obtained 
for the B.cereus I enzyme, where ultraviolet differnce 
spectra and cicular dichroism show large conformational 
changes during thermal denaturation in this temperature 
range (24). The active T71S mutant enzyme did not survive 
shipment to Santa Cruz(25). 
The fluoresence spectum of the wild-type pBR 322 beta-
lactamase isolated in this work shows that all fluorophores 
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are completely exposed to solvent at low temperature, in 
contrast to the B.cereus enzyme(25). Thus fluoresence chan-
ges cannot be used to monitor conformational changes in the 
E.coli enzyme. 
Proteolytic stability. All of the active-site mutants 
show a marked increase in susceptibility to proteolytic 
degradation. Figure IV-2 shows this increased susceptibility 
of the three active-site mutants to proteolytic digestion in 
E.coli. In late log phase, the mutant proteins are present, 
but in observably lower quantities than wild-type enzyme. 
After growth to stationary phase, the mutant proteins have 
almost completely vanished, while wild-type enzyme is still 
present in normal amounts. 
the two inactive mutants 
This figure also illustrates that 
(S70T, S70T-T71S) are even less 
resistant to cellular proteases than the active T71S mutant. 
Proteins of lower molecular weight that react with antibody, 
and that are absent from control cells, are also present; 
these presumably are proteolytic fragments of B-lactamase. 
This increased rate of proteolysis for the active T71S 
mutant can also be seen when a chemically well-defined prote-
ase is used. For example, the T71S mutant enzyme is drama-
tically more sensitive to thermolysin digestion at both 37°C 
and 45°C (Table IV-2) than the wild-type B-lactamase. The 
mutant protein was also more sensitive to digestion by TPCK-
treated trypsin; however, it was difficult to estimate half-
lives using trypsin due to the autolysis of the trypsin 
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during the assay. 
A similar but less 
seen if extruded active 
dramatic loss of enzyme activity is 
revertant enzyme 
E.coli periplasmic fluid. In 
shows no loss of activity after 
periplasmic fluid at 4oC. 
contrast, 
is incubated in 
wild-type enzyme 
three years of storage in 
Urea stability. The T71S revertant enzyme is also more 
sensitive to urea-induced denaturation than the wild-type 
enzyme. At 30oC and pH 7.0, the T71S enzyme is inactive at 
urea concentrations above 2 M, while wild-type enzyme is 
inactivated only at urea concentrations above 4 M. Both 
enzymes readily regain activity upon 50-fold dilution of 
urea, even after 48-h exposure at 37oC. (Note that these 
studies involve protein concentrations lower by a factor of 
at least 10 than those used in the studies of thermal stabil-
ity.) The ready reversibility of this urea-induced denatura-
tion compared to the irreversibility of thermal induced 
denaturation would seem to indicate that the denatured states 
produced by these two techniques differ dramatically. 
Discussion 
Though the mutation T71S does not drastically reduce 
catalytic activity, this change seriously destabilizes the 
three-dimensional structure of the protein. In the presence 
of proteases, as in the environment of the periplasmic space, 
the instability of the T71S mutant is significantly ampli-
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fied. The other two active site mutants (S70T-T71S and S70T) 
are equally as sensitive to degradation by the intrinsic 
E.coli proteases. Possibly, the mutant proteins have a 
conformation resembling pre-p- lactamase, which also has 
reduced catalytic activity and is highly susceptible to 
proteolytic attack(26,27). In interesting contrast, the 
mutant S70C, which retains Thr71, has enhanced thermal sta-
bility and resistance to proteolysis. (28) This is consistent 
with the observation that enzymes from thermophilic organisms 
often have threonine residues in the place of serine residues 
found in the ~arne enzymes in related mesophiles(l8). 
Summary 
The inability to isolate three active site mutant beta-
lactamases from E.coli following standard growth and purifi-
cation procedures suggested that these enzymes possessed 
reduced stability. Purified protein of the active T71S 
mutant enzyme has reduced resistance to thermal denaturation. 
In addition, this enzyme is digested more rapidly than the 
wild-type enzyme both in vitro by chemically defined prote-
ases such as thermolysin and trypsin as well as in vivo by 
E.coli proteases. The T71S enzyme is also denatured by lower 
urea concentrations than those required to denature the wild-
type enzyme. The inactive S70T and S70T-T71S mutants are 
even more sensitive to proteolytic degradation by E.coli 
proteases than the active T71S mutant is. 
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Table IV-1. Thermal Stability of Active ~-Lactamases 
ti 
Wild-Type Mutant 
Ser Thr Ser-ser 
400C 9 min 
45 5 min 
50 >30 min <1 min 
55 13 min 
60 1-2 min 
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Table IV-2 . Resistance of Wild-Type and Revertant ~­
Lactamases to Thermolysin Digestion 
Temperature 
3'rC 
4~C 
50 min 
18 min 
Revertant (ser~er) 
ti 
3.5 min 
<1 min 
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Figure IV-1. The thermal denaturation of wild-type pBR 322 
~-lactamase detected by circular dichroism. Assay condi-
tions are 3 ~M enzyme, 0.1 M cacodylic acid, 1M KCl, ph 
7.0. 
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Photograph of 
membrane from immune 
peroxidase stained 
blotting procedure 
showing beta-lactamase, its precursor, and an E.coli protein 
which also reacts with the antibody. Lanes 1-6, taken at 
late log phase; lane 7 is pure beta-lactamase control (0.14 
~g); lanes 7-12, taken 12 hours later. Amino acids listed 
below are the two active site residues, 70 and 71: samples 1 
and 8, thr-ser; 2 and 9, thr-thr; 3 and 10, ser-ser; 4 and 
11, ser-thr(wild type); 5, ser-stop(control, furnished by 
S.Schultz); 6, LS1(control, no plasmid) 
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CHAPTER V 
INVESTIGATION OF THE ROLE PLAYED BY 
THE DISULFIDE BOND IN PBR 322 
BETA-LACTAMASE 
97 
Introduction 
The role of disulfide bonds in maintaining the structure 
of secreted proteins and stabilizing the conformation of 
globular proteins has received considerable attention ( 1-3). 
However, many proteins with naturally occuring disulfide 
bonds have shown the ability to assume their native conforma-
tion and retain activity without the formation of these 
disulfide bonds. This suggests that disulfide bonds that may 
enhance conformational stability are not absolutely required 
for correct folding or function. 
The RTEM .B-lactamases encoded by the plasmids pBR322 
contain a single disulfide bond formed between cysteine 
residues at positions 77 and 123(4,5). This disulfide bond 
is formed as the protein is secreted from the cell. The 
disulfide bond present in wild-type pBR322 .B-lactamase cannot 
be reduced without using extreme conditions which denature 
this protein. Site-directed mutagenesis was used to replace 
cysteine 77, one of the residues that participates in the 
disulfide bond, with a serine residue(6). Serine was chosen 
as the replacement amino acid due to its similarity in size 
to cysteine(?). This mutation resulted in a .B-lactamase that 
resembled the wild-type enzyme when host-cell phenotypes were 
compared ( 6) . This chapter will discuss the catalytic pro-
perties and stability of the purified Cys77 to Ser mutant 
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~-lactamase. 
Similar removal of the naturally occurring disulfide 
bond from interleukin 2 by oligonucleotide mediated 
replacement of a cysteine by either alanine or serine 
resulted in mutant proteins with considerably lower activity 
than the wild-type enzyme(8,9). 
In addition to its use in studying the role of the 
disulfide bond in ~-lactamase, the C77S mutant protein may 
also prove useful in solving the structure of this protein by 
x-ray diffraction. By replacing cysteine residue 77 with 
serine, the remaing sulfhydryl of cysteine 123 is left free. 
This forms a potential binding site for heavy metal atoms 
such as mercury. A sample of this mutant protein was puri-
fied and a mercury derivative was prepared for this purpose. 
This approach for generating a free sulfhydryl group could 
also be used for the attachment of other probes, such as 
nuclear magnetic resonance or fluorescence labels, to a 
specific region of a protein. 
Materials and Methods 
Production of purified cys77 to Ser mutant protein. 
Plasmid pBR322 containing the C77S mutant ~-lactamase gene 
was furnished by Dr. G. Dalbadie-McFarland. Protein was 
produced using the procedures described 
Growth temperature was 30oC and ampicillin(20 
in Chapter II. 
mg/1) was used 
as the selecting antibiotic. The homogeneity of the protein 
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was determined by 12% SDS-PAGE followed by silver staining 
using standard procedures(lO). Protein concentrations were 
determined using a previously determined extinction coeffi-
cient of 29,400 M-lcm-1 at 281 nm for pure ~-lactamase(ll). 
Kinetic parameters of mutant protein. Catalytic parame-
ters of purified Cys77 to Ser protein were determined as in 
Chapter III using benzylpenicillin and cephalothin as sub-
strates. 
Catalytic activity as a function of temperature. The 
activity of purified 
varying temperatures 
All other conditions 
conditions. 
C77S mutant enzyme was measured at 
using benzylpenicillin as a substrate. 
were identical to the standard assay 
Thermal stability. Purified wild-type or mutant ~-lac-
tamase (0.1 mgjml in 0.1 M potassium phosphate, pH 7.0) was 
incubated at the specified temperatures in a shaking water 
bath. Aliquots were removed periodically and assayed for 
activity at 30oC using benzylpenicillin as the substrate. 
Values for the log of residual activity were plotted against 
time at each given temperature to determine the half-life of 
the enzyme . 
catalytic activity as a function of urea concentration. 
The activity of purified ~-lactamase to hydrolyze benzylpeni-
cillin in the presence of varying concentrations of urea was 
measured at 30 oC with all other conditions identical to the 
standard assay conditions. 
100 
Reaction with mercuria1s. Purified ~-1actamase (0.1 
mgjml) was treated with parahydroxy mercury benzoate or 
mercuric acetate ( 1 mM mercurial in 0.1 M potassium phos-
phate, pH=7.0) for 30 minutes at 30 oc. After this incuba-
tion, activity was determined using the standard assay. 
Preparation of mercury derivative for X-ray diffraction. 
Homogenous C77S ~-lactamase was rechromatographed on Ultragel 
AcA 54 to remove any proteolytic fragments which may have 
formed. The active protein eluted(6 mg) was concentrated to 
1 ml and the buffer changed to 50 mM potassium phosphate by 
ultrafililtration(Amicon PM-10 membrane). The concentrated 
protein was brought to 1 mM in mercuric acetate and allowed 
to react at room temperature overnight. After dialysis 
against distilled water, this material was concentrated to a 
small volume by repeated lyophilization of small aliquots in 
an eppendorf tube. The dried derivatized protein was shipped 
with no further processing. 
Results and Discussion 
Production and purification of C77S mutant ~-lactamase. 
No changes were necessary in the growth and purification 
procedures used to produce this mutant protein, although the 
growth temperature was maintained at 30oC to minimize pos-
sible thermal and proteolytic denaturation of this protein. 
No alterations in the behavior of this protein were observed 
during ammonium sulfate precipitation, ion-exchange chromate-
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graphy, and gel-filtration chromatography. No evidence for 
formation of dimers that could have resulted from formation 
of intermolecular disulfide bonds between the free sulfhyd-
ryl groups of Cys 123 was observed. The presence of such 
dimers, if significant amounts had formed, should have been 
evident especially on the Ultragel-54 gel filtration column. 
The mobility of the purified C77S protein on 12 % SDS-PAGE 
was identical to the wild-type enzyme. The yield of the C77S 
mutant was the same as that obtained from the wild-type 
enzyme(approximately 0.4 mKat or 6 mg protein from an 11 1 of 
culture). 
Kinetic parameters. The kinetic parameters (kcat and 
Krn) for the hydrolysis of benzylpenicillin and cephalothin 
by the C77S mutant protein are shown in Table V-1. At pH 7.0 
and 30oC, these parameters are virtually identical to those 
measured for the wild-type enzyme. Likewise, the activities 
of these enzymes were indistiguishable at saturating sub-
strate conditions ([benzylpenicillin]> 50 Krn) for tempera-
tures between 30oC and 40oC(Figure V-1). However, above this 
temperature, the activity of the C77S mutant becomes less 
than that of the wild-type enzyme, with denaturation taking 
place during the course of the assay. 
Thermal stability. The half-life of the C77S mutant at 
elevated temperatures was directly examined (Table V-2). The 
C77S mutant protein is less stable to thermal denaturation 
than the wild-type enzyme, with the mutant enzyme losing 
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activity at temperatures 5-10o lower than the wild-type 
enzyme. However, the mutant protein lacking the disulfide 
bond is still far more resistant to thermal denaturation than 
the T71S mutant enzyme, which still retains the disulfide. 
The half-lives presented in Table V-2 reflect an irreversible 
denaturation of the enzyme; I have not been able to restore 
activity to wild-type or mutant enzymes that have been 
thermally denatured as described in these experiments. 
Activity as a function of pH. The activity of the C77S 
mutant enzyme was also examined as a function of pH (Figure 
V-II). Between pH 6 and 8, the mutant enzyme are indisti-
guishable. Above pH 8, this mutant is less stable than the 
wild-type enzyme, while at low pH (below 6), the mutant 
appears slightly more active than the wild-type enzyme. This 
suggests that the loss of the proton from the free sulfhydryl 
group of Cys 123 may be involved in this loss of activity at 
higher pH. This is consistent with a similar loss of activ-
ity at elevated pH that has been seen for the T71C mutant of 
pBR 322 ~-lactamase(19). 
Resistance to proteases. The ability of the C77S to 
withstand E,coli periplasmic proteases was determined. At 
temperatures below 40o c, no difference in proteolytic sensi-
tivity was seen. As shown in Figure V-3, however, at ele-
vated temperatures the mutant protein lacking a disulfide is 
dramatically more sensitive to proteolysis. 
Reaction with mercurials. No inhibition of enzymatic 
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activity of the C77S beta-lactamase was observed a incubation 
with 1 mM parahydroxymercuric benzoate or 1 mM mercuric 
acetate. This implies that attachment of divalent mercury to 
the free cys 123 residue does not reduce activity. This 
evidence further suggests that this region of the beta-lac-
tamase is not intimately involved with the active site. 
Prolonged incubation of beta-lactamase, either 
wild-type, with these mercurial compounds results 
inactivation. 
mutant or 
in gradual 
The mercuric acetate derivative was purified and sent to 
Dr. J. Knox to aid in the resolution of the diffraction 
structure of beta-lactamase. Unfortunately, this protein did 
not produce a usable crystal. 
Summary 
The C77S mutant ~-lactamase was produced and purified to 
homogeneity. This protein was synthesized normally and 
showed no evidence for dimer formation. At temperatures 
below 40oC and in the pH range 5-8 it showed no differences 
in catalytic activity relative to the wild-type enzyme. 
Above 40oC or pH 8.0 this enzyme was less thermally stable 
than the wild-type enzyme. This mutant enzyme was also less 
resistant to proteolyis by intrinsic E.coli periplasmic 
proteases at high temperature. 
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Table V-1 Kinetic Parameters for Hydrolysis of Benzylpenicillin 
Cys 77+Ser 
Wild-type 
kcat s-1 
1950±200 
2000±200 
24±12 
26±10 
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Table V-2 Half-Lives of Mutant B-Lactamases (in minutes) 
Temperature (OoC) Wild-type Cys 77-+Ser Thr 71-+Ser 
40 ND >700* 9 
45 >1200* 40 5 
50 500 22 <1 
55 13 3.5 
60 1.5 
*At these temperatures the mutant enzymes retained at least 90% of their initial 
activity for the time indicated. 
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Figure V-1. Rate of benzylpenicillin hydrolysis as a func-
tion of temperature for the wild-type and C77S mutant ~-lac 
tamases. 
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Figure v-2. Rate of hydrolysis of benzylpenicillin by wild-
type (solid line, filled data points) and C77S mutant ~-lac­
tamase (open data points, dashed line) as a function of pH. 
The different shape data points represent different buffers. 
All buffer concentrations are 0.1 M: 0, potassium phosphate; •• potassium 
acetate;~. potassium glycine. 
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Figure V-3. Loss of enzymatic activity seen upon incubation 
of C77S mutant B-lactamase with E.coli periplasmic fluid at 
elevated temperature. No activity loss is seen for the 
wild-type enzyme under these conditions. 
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